SGO: Pembrolizumab-Chemo Combo Significantly Extends PFS in Endometrial Cancer
Recorded Courses
hosted byProjects In Knowledge Inc. (PIK)
hosted byProjects In Knowledge Inc. (PIK)
attend it anywhere online
category
Medicine
Oncology
price
Free
SGO: Pembrolizumab-Chemo Combo Significantly Extends PFS in Endometrial Cancer is organized by Projects In Knowledge Inc. (PIK).
Release Date: Mar 28, 2023
Termination Date: Mar 27, 2024
Activity Goal:
The goal of this CME/CE activity is to provide comprehensive and up-to-date information on the best practices in endometrial cancer
Learning Objective(s):
• Evaluate recent and current clinical trial data on immunotherapies and combination therapies for the treatment of endometrial cancer.
• Evaluate various treatment options in the second-line setting for endometrial cancer.
Additional details will be posted as soon as information is available.